Abstract:Abstract Sarcoidosis is a multisystem granulomatous disorder of uncertain aetiology, manifesting with cutaneous features in one-third of affected individuals. We retrospectively reviewed medical records of patients with a clinical diagnosis of cutaneous sarcoidosis in dermatology departments within our region. Sixty-five patients were identified. The mean age at presentation was 49 years (range 28–75), with increased prevalence in women (44, 68%). Twenty-six patients (40%) had localized disease affecting a single anatomical location, three of which were within tattoos. Thirty-nine (60%) had involvement of at least two anatomical locations. Limbs were the most frequently affected site (41). Other affected areas were the face (32), torso (25), scalp (9) and neck (5). Plaques were the most common morphology, seen in 26 cases, followed by papules (23), nodules (23), patches (6), erythema nodosum (4), annular (3), ulceration (3) and subcutaneous nodules (3). The colours of lesions were erythematous (37), yellow–orange–brown (22), violaceous (9) and skin coloured (5). All patients had biopsy-proven noncaseating granulomas; 60 patients had this confirmed on skin biopsy and five patients from other organs. In total, 41 patients (63%) had systemic sarcoidosis. Twenty-four of those with systemic sarcoid osis (59%) had cutaneous signs as their first presentation of sarcoid osis. Pulmonary sarcoidosis was diagnosed in 36 (55%), with relevant findings on chest X-ray, computed tomography of the thorax and/or pulmonary function tests. Of these, 22 patients did not report respiratory symptoms. Other organs involved were eye (6), joint (6), extrapulmonary lymph nodes (5), liver (4), cardiac (3), central nervous system (2) and renal (2). Lymphopenia was detected in 14 (22%) and anaemia in six (9%) patients. Twenty-three (35%) had elevated serum angiotensin-converting enzyme (ACE) levels. Four patients with elevated serum ACE levels did not have systemic sarcoidosis. Twenty-two of 41 patients with systemic sarcoidosis did not have elevated serum ACE levels. Complete resolution of skin lesions was observed in 32 patients. Management included watchful monitoring (8), potent or superpotent topical steroids (11), short courses of prednisolone (3), antimalarials (3), intralesional steroids (2), methotrexate (1), tofacitinib (1), and treatments initiated for systemic sarcoidosis including long-term prednisolone (3) and adalimumab (1). Our study highlights a lack of correlation between clinical features of cutaneous disease and systemic involvement. We found no association between biochemical profile and severity of sarcoidosis, or disease progression. It underscores the importance of maintaining a high index of suspicion and conducting thorough investigations for early detection of extracutaneous disease, as patients with extensive systemic sarcoidosis may be asymptomatic.

Analysis of the clinical data and definition methods of 96 cases with sarcoidosis

Clinical Features Analysis of 84 Patients with Sarcoidosis

Clinical Analysis of 27 Patients with Pulmonary Sarcoidosis

Analysis of the parenchymal lung lesions in sarcoidosis and the pathological diagnostic procedures

Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

Diagnostic value of 18F-FDG PET/CT for Sarcoidosis

Clinical analysis of sarcoidosis In elderly patients

[A Comparative Clinical Analysis of Thoracic Sarcoidosis and Multi-Organ Sarcoidosis].

Analysis of the Bronchospopic Diagnosis of Sarcoidosis

P111 A retrospective analysis of cutaneous sarcoidosis

[Clinical Analyses of Sarcoidosis with Ocular Involvement].

[Pleural Sarcoidosis: Report of Cases and Review of the Literature].

Value of mediastinoscopy in the diagnosis of stage Ⅰ thoracic sarcoidosis

Recent advances in sarcoidosis

Increased Serum Sedimentation and Positive Tuberculosis Antibody Combined Multiple Pulmonary Nodules in Chest CT in a Middle-Aged Patient Firstly Misdiagnosed As Tuberculosis Proved As Sarcoidosis by CT Guided Percutaneous Lung Puncture Biopsy: a Case Report and Literature Review

Diagnostic Difficulties and Search for New Criteria of Inflammatory Activity (A Case Report and Literature Review)

Re-evaluating serum angiotensin-converting enzyme in sarcoidosis

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

Endobronchial lesions of sarcoidosis

[The value of bronchoscopy in the diagnosis of sarcoidosis]

Role of Bronchoscopy in Diagnosis of Sarcoidosis